Search Results - "Kaminetsky, Jed C"

Safety of a New Subcutaneous Testosterone Enanthate Auto-Injector: Results of a 26-Week Study by Gittelman, Marc, Jaffe, Jonathan S., Kaminetsky, Jed C.

“…Patients with testosterone deficiency (TD) can be treated with exogenous testosterone (T) to achieve and maintain physiologic T levels and prevent negative…”
Get full text

A 52-Week Study of Dose Adjusted Subcutaneous Testosterone Enanthate in Oil Self-Administered via Disposable Auto-Injector by Kaminetsky, Jed C, McCullough, Andrew, Hwang, Kathleen, Jaffe, Jonathan S, Wang, Christina, Swerdloff, Ronald S

“…In this open label, single arm, dose blinded, 52-week registration phase study we evaluated the efficacy and safety of a subcutaneous testosterone enanthate…”
Get full text

Efficacy and Safety of Sildenafil by Age in Men With Erectile Dysfunction by Goldstein, Irwin, Tseng, Li-Jung, Creanga, Dana, Stecher, Vera, Kaminetsky, Jed C.

“…Sildenafil, an oral phosphodiesterase type 5 inhibitor, has been extensively investigated for the treatment of erectile dysfunction in randomized controlled…”
Get full text

Diagnostic performance of PCA3 to detect prostate cancer in men with increased prostate specific antigen: a prospective study of 1,962 cases by Crawford, E David, Rove, Kyle O, Trabulsi, Edouard J, Qian, Junqi, Drewnowska, Krystyna P, Kaminetsky, Jed C, Huisman, Thomas K, Bilowus, Mark L, Freedman, Sheldon J, Glover, Jr, W Lloyd, Bostwick, David G

“…The detection of prostate cancer relies primarily on abnormal digital rectal examination or increased serum prostate specific antigen concentration. However,…”
Get more information

Tadalafil relieves lower urinary tract symptoms secondary to benign prostatic hyperplasia by McVary, Kevin T, Roehrborn, Claus G, Kaminetsky, Jed C, Auerbach, Stephen M, Wachs, Barton, Young, Jay M, Esler, Anne, Sides, Gregory D, Denes, Bela S

“…We assessed the efficacy and safety of tadalafil dosed once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia. Following a…”
Get more information

Summative Usability Evaluation of the SCTE-AI Device: A Novel Prefilled Autoinjector for Subcutaneous Testosterone Administration by Arora, Samir, Moclair, Betsy, Murphy, Kyle, Jaffe, Jonathan S., Kaminetsky, Jed C.

“…The subcutaneous testosterone enanthate (TE) autoinjector (SCTE-AI) is a single-use, pre-filled, disposable autoinjector intended for testosterone (T)…”
Get full text

Adulteration of Purported Herbal and Natural Sexual Performance Enhancement Dietary Supplements with Synthetic Phosphodiesterase Type 5 Inhibitors by Campbell, Neil, Clark, John P., Stecher, Vera J., Thomas, John W., Callanan, Amy C., Donnelly, Brian F., Goldstein, Irwin, Kaminetsky, Jed C.

“…Many products labeled “herbal” or “all natural” (herbal/natural) that claim to enhance sexual performance and imply use for the treatment of erectile…”
Get full text

Quality of erections by age group in men with erectile dysfunction by Kaminetsky, Jed C, Stecher, Vera, Tseng, Li-Jung

“…The aim of this study was to assess erection quality with sildenafil vs placebo and adverse events (AEs) according to age (≤45, 46-55 and ≥56 years) in 997 men…”
Get more information

Correlations with satisfaction measures in men treated with phosphodiesterase inhibitors for erectile dysfunction by Mulhall, John P, Kaminetsky, Jed C, Althof, Stanley E, Goldstein, Irwin, Creanga, Dana L, Marfatia, Aditya, Symonds, Tara, Budhwani, Meeta

“…This literature review examined the relationship of erectile function to patient satisfaction. Published correlation coefficients (r values) were sought…”
Get full text

A Phase IV Prospective Evaluation of the Safety and Efficacy of Extended Release Testosterone Pellets for the Treatment of Male Hypogonadism by Kaminetsky, Jed C., Moclair, Betsy, Hemani, Micah, Sand, Matthew

“…Men with hypogonadism exhibit decreased serum testosterone levels and may experience a constellation of clinical symptoms, including decrease in muscle mass,…”
Get full text

Changes in peak urinary flow and voiding efficiency in men with signs and symptoms of benign prostatic hyperplasia during once daily tadalafil treatment by Roehrborn, Claus G., Kaminetsky, Jed C., Auerbach, Stephen M., Montelongo, Rafael Martínez, Elion‐Mboussa, Albert, Viktrup, Lars

“…Study Type – Therapy (RCT)
Level of Evidence 1b OBJECTIVE To determine, by post hoc analysis, the effects of tadalafil (a long‐acting phosphodiesterase 5…”
Get full text

PD37-08 EFFICACY AND PHARMACOKINETICS OF LPCN 1021, A NOVEL ORAL TESTOSTERONE REPLACEMENT THERAPY (TRT), IN HYPOGONADAL MEN: STUDY OF ANDROGEN REPLACEMENT (SOAR) by Kaminetsky, Jed C, DelConte, Anthony, Dobs, Adrian S, Wang, Christina, Yadav, Pavan, Venkateshwaran, Srinivasan, Chidambaram, Nachiappan, Nachaegari, Satish, Patel, Mahesh, Miner, Martin M

Get full text

Comorbid LUTS and erectile dysfunction: optimizing their management by Kaminetsky, Jed C.

“…ABSTRACT Background and scope: Lower urinary tract symptoms (LUTS) related to benign prostatic hyperplasia (BPH), and sexual dysfunction such as erectile…”
Get full text

In Men with Erectile Dysfunction, Satisfaction with Quality of Erections Correlates with Erection Hardness, Treatment Satisfaction, and Emotional Well-Being by Kaminetsky, Jed C., Depko, Andrzej J., Ströberg, Peter, Buvat, Jacques, Tseng, Li-Jung, Stecher, Vera J.

“…The validated Quality of Erection Questionnaire (QEQ) evaluates satisfaction with erection quality. To collate QEQ data, including correlations between QEQ…”
Get full text

Benefits of a new testosterone gel formulation for hypogonadal men by Kaminetsky, Jed C.

“…Hypogonadism is a common problem in men. It affects 2% to 30% of men aged 40 to 59 years, 20% to 45% aged 60 to 69 years, 34% to 70% aged 70 to 79 years, and…”
Get full text

Testosterone therapy in hypogonadal men. Introduction by Kaminetsky, Jed C

Get full text

PD21-03 EFFICACY OF A COIN-SIZED TIBIAL NEUROSTIMULATOR FOR URGENCY URINARY INCONTINENCE: INTERIM PIVOTAL RESULTS by Rogers, Alexandra E., McCrery, Rebecca J., Sen, Subhro K., Ferrante, Kimberly L., Lukban, James C., Sand, Peter K., Dutta, Sonia, Kaaki, Bilal R., Shapiro, Andrew M., Mills, Owings, Serels, Scott R., Giudice, Thomas P., Nguyen, John N., Gauta, Joseph, Kaminetsky, Jed C., Threatt, Chris B., Lucente, Vincent R., MacDiarmid, Scott A.

Get full text

Efficacy and Safety of Sildenafil by Age in Men With Erectile Dysfunction: Pharmacotherapy by Goldstein, Irwin, Tseng, Li-Jung, Creanga, Dana, Stecher, Vera, Kaminetsky, Jed C

“…Introduction Sildenafil, an oral phosphodiesterase type 5 inhibitor, has been extensively investigated for the treatment of erectile dysfunction in randomized…”
Get full text

Introduction by Kaminetsky, Jed C.

Get full text